PBM Nutritionals, LLC has recalled 16,500 units of CVS Health brand and HEB Baby brand Premium Infant Formula with Iron Milk-Based Powder. The product was found to contain Vitamin D at levels exceeding the maximum amount permitted. No illnesses or injuries have been reported to date. This infant formula was sold in 964g cans in states including TX, FL, CA, SC, VA, IN, TN, NJ, MI, PA, RI, and MO.
The formula contains Vitamin D above the legal safety limit, which can pose health risks to infants if consumed over time. While no injuries have been reported, excessive Vitamin D intake in babies can lead to serious health complications.
You have 2 options:
CVS Health brand; packaged in composite cans; 4 cans per case.
HEB Baby brand; packaged in composite cans; 4 cans per case.

Front of Can, CVS Health Premium Infant Formula with Iron Milk-Based Powder

Bottom of Can, CVS Health Premium Infant Formula with Iron Milk-Based Powder

Front of Can, H-E-B Baby Premium Infant Formula with Iron Milk-Based Powder

Bottom of Can, H-E-B Baby Premium Infant Formula with Iron Milk-Based Powder

Bottom of Can, Premium Infant Formula with Iron Milk-Based Powder
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.